| Fiscal period | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Period End Date | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 |
|---|
| Product | 3,020.00 | 3,632.50 | 3,539.90 | 3,078.10 | 2,845.00 | 2,867.70 | 3,107.10 | 3,446.20 | 3,528.90 | 3,563.10 |
| Service | 2,053.60 | 1,932.00 | 1,761.30 | 1,657.30 | 1,600.10 | 1,577.70 | 1,540.40 | 1,581.00 | 1,461.20 | 1,294.70 |
| Total Revenues | 5,073.60 | 5,564.50 | 5,301.20 | 4,735.40 | 4,445.10 | 4,445.40 | 4,647.50 | 5,027.20 | 4,990.10 | 4,857.80 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of revenues- Product | 1,509.50 | 1,781.60 | 1,761.70 | 1,409.40 | 1,278.60 | 1,227.00 | 1,277.20 | 1,360.90 | 1,326.20 | 1,269.60 |
| Cost of revenues- Service | 582.60 | 581.00 | 581.20 | 585.90 | 592.80 | 601.60 | 629.10 | 594.20 | 559.40 | 509.60 |
| Gross Profit | 2,981.50 | 3,201.90 | 2,958.30 | 2,740.10 | 2,573.70 | 2,616.80 | 2,741.20 | 3,072.10 | 3,104.50 | 3,078.60 |
| Impairment of goodwill and intangible assets | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- |
| Amortization of goodwill, purchased intangibles and deferred stock compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of purchased intangibles | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of deferred stock compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research and development | 1,150.50 | 1,144.40 | 1,036.10 | 1,007.20 | 958.40 | 955.70 | 1,003.20 | 980.70 | 1,013.70 | 994.50 |
| In-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| General and Administrative | 245.80 | 255.50 | 249.50 | 249.80 | 255.40 | 244.30 | 231.10 | 227.50 | 224.90 | 228.90 |
| Sales and marketing | 1,221.40 | 1,233.90 | 1,133.40 | 1,052.70 | 938.80 | 939.30 | 927.40 | 950.20 | 972.90 | 943.80 |
| Integration costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Merger-related charges | 61.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Acquisition-related charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Restructuring, impairments, and special charges | 10.10 | 98.00 | 20.20 | 42.90 | 68.00 | 35.30 | 7.30 | 65.60 | 3.30 | (0.60) |
| Other charges, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2,689.70 | 2,731.80 | 2,439.20 | 2,352.60 | 2,220.60 | 2,174.60 | 2,169.00 | 2,224.00 | 2,214.80 | 2,166.60 |
| Operating income | 291.80 | 470.10 | 519.10 | 387.50 | 353.10 | 442.20 | 572.20 | 848.10 | 889.70 | 912.00 |
| Interest and other expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Write-down of equity investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain (Loss) on sale of investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (Loss) on redemption of convertible subordinated notes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain (loss) on sale of equity or available-for-sale investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain (loss) on privately-held investments, net | 0.70 | (97.30) | -- | -- | -- | -- | -- | -- | -- | -- |
| Equity in net Earnings (loss) of joint venture | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and other income (expense) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other (expense) income, net | 5.50 | (23.80) | (28.60) | (16.80) | (32.90) | (27.80) | (39.50) | (36.30) | (62.30) | (59.80) |
| Gain on divestiture | -- | -- | 45.80 | -- | -- | -- | -- | -- | -- | -- |
| Loss on extinguishment of debt | -- | -- | -- | (60.60) | (55.00) | -- | -- | -- | -- | -- |
| Income (loss) before income taxes | 298.00 | 349.00 | 536.30 | 310.10 | 265.20 | 414.40 | 532.70 | 811.80 | 827.40 | 852.20 |
| Provision for income taxes | 0.50 | 29.20 | 60.50 | 57.40 | 7.40 | 69.40 | (34.20) | 505.60 | 234.70 | 218.50 |
| Loss from equity method investment, net of tax | (9.60) | (9.60) | (4.80) | -- | -- | -- | -- | -- | -- | -- |
| Consolidated Net Income (Loss) | 287.90 | 310.20 | 471.00 | 252.70 | 257.80 | 345.00 | 566.90 | 306.20 | 592.70 | 633.70 |
| Net income/ loss attributable to noncontrolling interest | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Available to Common Shareholders | 287.90 | 310.20 | 471.00 | 252.70 | 257.80 | 345.00 | 566.90 | 306.20 | 592.70 | 633.70 |
| Net Earnings Per Share (Basic) | 0.88 | 0.97 | 1.46 | 0.78 | 0.78 | 1.01 | 1.62 | 0.81 | 1.55 | 1.62 |
| Net Earnings Per Share (Diluted) | 0.86 | 0.95 | 1.43 | 0.76 | 0.77 | 0.99 | 1.60 | 0.80 | 1.53 | 1.59 |
| Weighted Average Shares Outstanding (Basic) | 327.20 | 320.00 | 322.10 | 324.40 | 330.40 | 343.20 | 349.00 | 377.70 | 381.70 | 390.60 |
| Weighted Average Shares Outstanding (Diluted) | 334.60 | 325.90 | 329.50 | 331.60 | 335.20 | 348.20 | 354.40 | 384.20 | 387.80 | 399.40 |